PLA2G4A and Alzheimer disease: Using a mouse model of AD based on the hippocampal injection of Aβ42, the authors further examined the effects of intraperitoneal administration of taxifolin on the levels of cPLA2 and of the synaptic marker post-synaptic density protein-95 (PSD-95) and on cognitive function [42].